NCT06806696 SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA Status COMPLETED Phase N/A
NCT06795880 "Artificial Intelligence-Based Data Analysis Results and Mortality Prediction in Covid-19 Patients in Intensive Care" Status COMPLETED Phase N/A
NCT06789952 Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia Status TERMINATED Phase NA
NCT06780566 Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial Status NOT_YET_RECRUITING Phase NA
NCT06776367 Project REMOTE (REimagining Measurements and Operations of Translational Endpoints) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06767241 Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients Status COMPLETED Phase NA
NCT06751017 A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06744660 Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test Status RECRUITING Phase NA
NCT06743334 Secondary Databased Post-marketing Surveillance Study of BNT162b2 Status COMPLETED Phase N/A
NCT06742281 A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults Status COMPLETED Phase PHASE2
NCT06734741 Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use Status COMPLETED Phase N/A
NCT06727474 Clinical and Functional Characteristics of Patients Admitted for Severe COVID-19 Pneumonia Status COMPLETED Phase N/A
NCT06723821 Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain Status COMPLETED Phase NA
NCT06703190 Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine Status TERMINATED Phase N/A
NCT06703034 Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19 Status RECRUITING Phase NA
NCT06694389 Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age Status COMPLETED Phase PHASE3
NCT06690502 Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination Status COMPLETED Phase N/A